Community-acquired pneumonia: clinical approaches

Oral Presentation
Chairs: F. Blasi (Milan, Italy), W. Boersma (Alkmaar, The Netherlands)

Audit of the management of patients admitted to a Dublin teaching hospital with community acquired pneumonia between October 2003 and February 2004 S. C. Foley, E. M. Kelly, S. J. O‘Neill (Dublin, Ireland)
Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP) E. Tabernero, J. Lobo, M. Sanchez, P. Lopetegui, V. Zorrilla, P. Espana (Vitoria-Gasteiz, Vizcaya, Spain)
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP T. T. Bauer, T. Welte, R. Marre, N. Suttorp, CAPNETZ Investigators (Bochum, Hannover, Ulm, Berlin, Germany)
Diagnostic value of signs, symptoms and laboratory parameters in bacterial lower respiratory tract infection D. Stolz, M. Christ-Crain, R. Bingisser, M. Gencay, P. Huber, B. Müller, M. Tamm (Basel, Switzerland)
CURB-65 clinical prediction rule in invasive pneumococcal disease (IPD) C. Feldman, G. A. Richards, K. P. Klugman, V. Yu (Johannesburg, South Africa; Atlanta, Pittsburgh, United States Of America)
Quality-indicators and prognostics in CAP in three populations C. N. Meyer, S. Novovic, A. Løkke (Hvidovre, Copenhagen, Denmark)
Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) P. G. Dambrava, G. Peñarroja, I. Aldabo, M. A. Marcos, M. Camps, M. Sanchez, R. Estruch, M. Valencia, J. Mensa, A. Torres (Barcelona, Spain)
A novel approach in the treatment of aspiration pneumonia and primary lung abscess S. Ott, M. Allewelt, G. Korfmann, A. Kureishi, J. Lorenz, H. Lode (Berlin, Wuppertal, Luedenscheid, Germany)